BACK TO OVERVIEW

Bioinformatics Cloud for no-code, end-to-end bioinformatic workflows

PipeBio is revolutionizing drug development by offering a no-code, cloud-based SaaS bioinformatics platform that accelerates the creation of therapeutics 10x faster. Their platform integrates configurable sequence and assay-data databases with a robust analytical engine for large NGS datasets, REST API, and intuitive visualization tools. Designed to structure data for machine learning and AI applications, PipeBio empowers the scientific community to optimize the development of antibodies and antibody-like therapeutics.

“No-code bioinformatics is the missing piece with the power to merge two revolutions: in-silico life science, and engineering tools for non-coders. By joining these independent innovation forces, PipeBio is helping enable tomorrow's great biological advancements."

Torsten Kolind, byFounders Collective member

VERTICAL
HealthTech
Country
Denmark
INvested in
Pre-Seed
2021
Invested with
Collective contributions

Meet the founders

Jannick Bendtsen

CEO

Owen Bodley

CTO

Related news

External
October 29, 2021

Why we Invested in PipeBio: no-code SaaS for bioinformatics and drug development

The human costs of the pandemic forced the scientific community to rethink how processes, such as drug development, can be done 10x faster than before. PipeBio is at the frontline of that development.
Portfolio News
October 29, 2021

Why we Invested in PipeBio: no-code SaaS for bioinformatics and drug development

The human costs of the pandemic forced the scientific community to rethink how processes, such as drug development, can be done 10x faster than before. PipeBio is at the frontline of that development.

Delete me when done